Discover 1,776 paid clinical trials in High Point, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,776
Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients
A Study of PHN-012 in Patients With Advanced Solid Tumors
for
Colon Cancer, Pancreatic Cancer, Lung Cancer (NSCLC),
Location: Durham NC, Fairfax VA, Washington D.C. DC, Nashville TN,
Sponsor: Pheon Therapeutics
Sex: All
Age: 18+
Code: NCT07127874
Phase 1, Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
for
Endometrial Cancer
Location: Durham NC, Pinehurst NC, Richmond VA, Fairfax VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06952504
Phase 3, Recruiting
Improving Hypertension Control in Rheumatoid Arthritis
for
Hypertension, Rheumatoid Arthritis
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT05760898
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy
for
Bladder Cancer
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06986304
Recruiting
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
for
Breast Cancer, Locally Advanced Breast Cancer,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: Female
Age: 18+
Code: NCT06727773
Phase 2, Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
for
Endometrial Adenocarcinoma,
Location: Durham NC, Raleigh NC, Charlottesville VA, Richmond VA,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT05112601
Phase 2, Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
for
Lung Non-Small Cell Carcinoma
Location: Durham NC, Pinehurst NC, Charlotte NC, Raleigh NC,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07388524
Phase 3, Recruiting
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
for
Desmoplastic Small Round Cell Tumor, Osteosarcoma,
Location: Durham NC, Washington D.C. DC, Atlanta GA, Baltimore MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12 - 39
Code: NCT04616560
Phase 2, Recruiting
Continued Pressure for Alveolar Protection (CPAP Trial)
for
Bronchopulmonary Dysplasia (BPD)
Location: Durham NC, Atlanta GA, Cincinnati OH, Philadelphia PA,